2019
DOI: 10.1080/03079457.2018.1556778
|View full text |Cite
|
Sign up to set email alerts
|

Induction of IBV strain-specific neutralizing antibodies and broad spectrum protection in layer pullets primed with IBV Massachusetts (Mass) and 793B vaccines prior to injection of inactivated vaccine containing Mass antigen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
21
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 42 publications
3
21
1
Order By: Relevance
“…Also, such a combined approach in IB vaccination could also explored in the control of emerging IBVs and other coronaviruses variants [ 40 ]. Overall, our findings on the immunogenic potentials of the DNA vaccine is consistent with other studies who demostrated good immunogenic response and good protection following immunization with a vaccine containing the combinations of Massachussets and other IBV strains such as the 793B [ 41 , 42 ] or QX-like and Dutch strains [ 40 ].…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Also, such a combined approach in IB vaccination could also explored in the control of emerging IBVs and other coronaviruses variants [ 40 ]. Overall, our findings on the immunogenic potentials of the DNA vaccine is consistent with other studies who demostrated good immunogenic response and good protection following immunization with a vaccine containing the combinations of Massachussets and other IBV strains such as the 793B [ 41 , 42 ] or QX-like and Dutch strains [ 40 ].…”
Section: Discussionsupporting
confidence: 91%
“…Similarly, another study reported that a DNA plasmid encoding S1 gene resulted in 75% protection in challenged chickens, thus further demostrating the immunogenic potentials of IBV S1 glycoprotein [ 39 ]. The protection observed in this study interms of reduced virus sheddings, low kidney and tracheal lesion scores as well as reduced clinical signs have been reported in other similar studies [ 40 , 41 ], and might not be unconnected to the numerous immunogenic epitopes situated within the S1-glycoprotein of the two virus strains [ 29 ]. Also, such a combined approach in IB vaccination could also explored in the control of emerging IBVs and other coronaviruses variants [ 40 ].…”
Section: Discussionsupporting
confidence: 87%
“…As a member of the genus Gammacoronavirus, IBV has a remarkably high mutation and recombination rate, leading to numerous types and variants that differ from each other in pathogenicity [2,3]. Although the site of entry of IBV is the upper respiratory tract, where the initial infection occurs, the virus can spread systemically, replicating in the epithelial cells of many organs and causing injuries of the kidneys and female reproductive tract [4]. The kidney, trachea, caecal tonsil, and cloaca have been demonstrated to be tissues in which the long-term persistence of IBV is observed [5].…”
Section: Introductionmentioning
confidence: 99%
“…Our results showed that HY could inhibit IBV infection and inhibit apoptosis and production of ROS in CEK cells. It has been reported that there were multiple known strains of IBV, IBV strain M41, is typical respiratory virus, which replicates primarily in the respiratory tract and subsequently spreads and replicates in a range of other tissues (De Wit et al, 2019;Hodgson et al, 2004). The CEK cells are the most susceptible cells of strain M41 in vitro (Abdel-Moneim et al, 2009;Zhang et al, 2017).…”
Section: Discussionmentioning
confidence: 99%